bioAffinity Technologies Forms Subsidiary to Focus on Targeted Cancer Drug Delivery
23 juin 2016 08h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, June 23, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies today announced the formation of OncoSelect Therapeutics, LLC, a subsidiary company that will leverage bioAffinity’s...